Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

UK shareholder meetings calendar - next 7 days

2nd Apr 2026 12:07

AstraZeneca hails encouraging data for liver cancer drug regimen

2nd Apr 2026 10:46

(Alliance News) - AstraZeneca PLC on Thursday posted encouraging phase-three trial results for its liver cancer treatment combination. Read More

AstraZeneca says hypophosphatasia replacement enzyme trials positive

31st Mar 2026 10:03

(Alliance News) - AstraZeneca PLC on Tuesday said phase-three testing of its replacement efzimfotase alfa enzyme on patients affected by hypophosphatasia yielded positive safety and efficacy results. Read More

LONDON MARKET CLOSE: FTSE 100 ends down as oil rises amid war deadlock

27th Mar 2026 17:07

(Alliance News) - Blue chips in London outperformed European and US peers on Friday, but closed marginally lower, as oil prices rose once more amid few signs of progress in ending the Iran war. Read More

LONDON MARKET MIDDAY: Shares slide as Iran tensions deepen

27th Mar 2026 12:02

(Alliance News) - Stock prices in London were lower at midday Friday, with losses accelerating after a muted open as conflicting signals over Iran weighed on sentiment. Read More

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay

27th Mar 2026 10:30

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

LONDON MARKET OPEN: Stocks mixed as Brent oil nears USD110

27th Mar 2026 09:04

(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 edging higher despite continued uncertainty regarding Iran peace talks and muted sentiment across European markets. Read More

AstraZeneca hails positive results in tozorakimab lung disease trials

27th Mar 2026 08:26

(Alliance News) - AstraZeneca PLC on Friday reported positive phase-three trial results for its chronic obstructive pulmonary disease treatment tozorakimab. Read More

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

27th Mar 2026 07:56

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More

Daiichi Sankyo's cancer drug approved as second-line therapy in Japan

23rd Mar 2026 19:13

(Alliance News) - Daiichi Sankyo Co Ltd announced on Monday that Japan's Pharmaceuticals and Medical Devices Agency has approved an update to the prescribing information for its Enhertu treatment, expanding its use to second-line treatment of HER2-positive unresectable advanced or recurrent gastric cancer in Japan. Read More

UK dividends calendar - next 7 days

16th Mar 2026 11:36

LONDON MARKET OPEN: Shares down as Middle East tensions rise

11th Mar 2026 09:21

(Alliance News) - Stock prices in London opened lower on Wednesday, as renewed tensions in the Middle East stemming from the Israel-US war against Iran kept investors in a cautious mood. Read More

LONDON BRIEFING: Astra drug wins US review as oil surges above USD100

9th Mar 2026 08:02

(Alliance News) - AstraZeneca secures US priority review for Enhertu, GSK agrees linerixibat deal with Alfasigma, while AdvancedAdvT rules out M&C Saatchi bid. Read More

AstraZeneca and Daiichi secure US fast-track status for cancer drug

9th Mar 2026 07:03

(Alliance News) - AstraZeneca PLC and Daiichi Sanyko Co Ltd on Monday reported that their co-developed breast cancer treatment Enhertu had secure priority review status in the US. Read More

LONDON BROKER RATINGS: ITV raised; JPMorgan ups AIB, Bank of Ireland

6th Mar 2026 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

AstraZeneca prices USD2 billion multi-year bond issuance

26th Feb 2026 10:03

(Alliance News) - AstraZeneca PLC on Thursday priced a global bond offering worth USD2 billion. Read More

LONDON BROKER RATINGS: Santander cuts BP; Berenberg likes Cairn Homes

26th Feb 2026 09:59

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET OPEN: Mixed start in Europe; Rolls-Royce shares climb

26th Feb 2026 09:21

(Alliance News) - European stocks were mixed in early dealings on Thursday, with markets awaiting a fresh set of catalysts after Nvidia beat on earnings overnight. Read More

LONDON MARKET CLOSE: HSBC reclaims top spot as FTSE 100 hits new high

25th Feb 2026 17:07

(Alliance News) - The FTSE 100 reached fresh heights on Wednesday, with well-received results from HSBC, and gains in mining stocks, paving the way for another record-breaking day. Read More

Avacta hails new data supporting proprietary preCision platform

24th Feb 2026 11:06

(Alliance News) - Avacta Group PLC on Tuesday saw its shares rise, as it said new data demonstrates a favourable delivery profile and advantages of its preCision platform when compared to a marketed antibody drug conjugate. Read More

FTSE 100 Latest

Value10,603.48

Change-5.40